fludeoxyglucose (18f)

Poland

Drugs containing this active substance

  • FDG POZYTON

    The medicinal product is used exclusively for diagnostic purposes in a procedure called positron emission tomography (PET). It allows for the imaging of individual parts of the body, enabling the doctor to obtain more information about the disease and its progression.

    Form: solution for injection

    Active substance Dosage
    fludeoxyglucose (18f) 250-3100 MBq/ml

    ATC: V09IX04

    Manufacturer: Franciszek Łukaszczyk Oncology Center in Bydgoszcz

  • The medicinal product is used exclusively for diagnostic purposes in positron emission tomography (PET) scans. It allows for the imaging of specific parts of the body, enabling the doctor to obtain more information about the disease and its progression.

    Form: solution for injection

    Active substance Dosage
    fludeoxyglucose (18f) 550 MBq

    ATC: V09IX04

    Manufacturer: Maria Skłodowska-Curie National Institute of Oncology - State Research Institute, Branch in Gliwice

  • This is a radiopharmaceutical product used exclusively for diagnostic purposes. After intravenous administration, it allows the physician to perform radiographic imaging, which helps determine the location or progression of a disease.

    Form: solution for injection

    Active substance Dosage
    fludeoxyglucose (18f) 200-2200 MBq/ml

    ATC: V09IX04

    Manufacturer: Synektik Pharma Sp. z o.o.

  • This is a preparation used exclusively for diagnostic imaging. After injection, it helps the doctor locate a disease or assess its progression.

    Form: solution for injection

    Active substance Dosage
    fludeoxyglucose (18f) 100-1500 MBq/ml

    ATC: V09IX04

    Manufacturer: ÚJV Řež, Inc.

  • This is a product used exclusively for diagnostic purposes. After injection, it allows the physician to perform imaging studies of parts of the body, enabling the localization of a disease or determining whether it is progressing in the body.

    Form: solution for injection

    Active substance Dosage
    fludeoxyglucose (18f) 300-3100 MBq/ml

    ATC: V09IX04

    Manufacturer: Alliance Medical RP Berlin GmbH

  • This is a radiopharmaceutical preparation used exclusively for diagnostic purposes. It enables imaging studies (e.g., tomography), which allow a physician to assess a patient's health status or treatment progress.

    Form: solution for injection

    Active substance Dosage
    fludeoxyglucose (18f) 1 GBq/ml

    ATC: V09IX04

    Manufacturer: Synektik Pharma Ltd.

  • This is a radiopharmaceutical product used exclusively for diagnostic purposes. It helps the doctor locate a disease or assess its progression during imaging of the body's interior.

    Form: solution for injection

    Active substance Dosage
    fludeoxyglucose (18f) 250 MBq/ml

    ATC: V09IX04

    Manufacturer: Centrum Produkcji Radiofarmaceutyków S.A. GE Healthcare B.V. GE Healthcare S.r.L. C/o Joint Research Centre Norsk medisinsk syklotronsenter AS

  • It is a radiopharmaceutical product used for diagnostic purposes during positron emission tomography (PET/CT) scans. It helps to image changes in glucose metabolism in the body, which assists doctors in making decisions regarding disease treatment.

    Form: solution for injection

    Active substance Dosage
    fludeoxyglucose (18f) 15 ml

    ATC: V09IX04

    Manufacturer: Centrum Produkcji Radiofarmaceutyków Voxel S.A.